Schering’s Zetia Promotion To Physicians Draws Inquiry From Sen. Kohl
Executive Summary
Senate Aging Committee Chairman Herb Kohl, D-Wisc. requests that Schering-Plough provide information on a recent physician-aimed marketing campaign for Zetia (ezetimibe), in a March 13 letter to the firm
You may also be interested in...
Academic Detailing Bill Could Be Interim Step To Comparative Effectiveness
Congressional critics of pharmaceutical marketing practices launched another volley in their battle to curb industry influence on prescribers with the July 31 introduction of legislation that would create a federally-supported "academic detailing" program
Academic Detailing Bill Could Be Interim Step To Comparative Effectiveness
Congressional critics of pharmaceutical marketing practices launched another volley in their battle to curb industry influence on prescribers with the July 31 introduction of legislation that would create a federally-supported "academic detailing" program
Off-Label Dissemination Keeps FDA Stuck Between Prosecutors And Firms
As industry weighs the potential impact of FDA's guidance on good reprint practices, stakeholders are suggesting alternate policy approaches that could give companies sufficient clarity on how to conduct off-label dissemination